The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Buyer Name: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Buyer Address: 1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB, United Kingdom
Contact Name: Stephanie McNiven
Contact Email: stephanie.mcniven2@nhs.scot
Contact Telephone: +44 1312756000
Supply of Cytokine Modulators to NHS Scotland.
No linked documents found for this notice.
Lot Title: Etanercept
Lot Description: Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Lot 1 Status: cancelled
Lot 1 Has Options: No
Lot 1 Award Criterion (quality): API Sources
Lot Title: Infliximab IV
Lot Description: Supply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.
Lot 2 Status: cancelled
Lot 2 Has Options: No
Lot 2 Award Criterion (quality): API Sources
Lot Title: Infliximab SC
Lot Description: Supply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line.
Lot 3 Status: cancelled
Lot 3 Has Options: No
Lot 3 Award Criterion (quality): API Sources
Lot Title: Methotrexate syringes (25mg/1 ml concentration)
Lot Description: Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Lot 4 Status: cancelled
Lot 4 Has Options: No
Lot 4 Award Criterion (quality): API Sources
Lot Title: Methotrexate pens (25mg/1ml concentration)
Lot Description: Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Lot 5 Status: cancelled
Lot 5 Has Options: No
Lot 5 Award Criterion (quality): API Sources
Lot Title: Methotrexate pens (50mg/1 ml concentration)
Lot Description: Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Lot 6 Status: cancelled
Lot 6 Has Options: No
Lot 6 Award Criterion (quality): API Sources
Lot Title: Methotrexate syringes (50mg/1ml concentration)
Lot Description: Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.
Lot 7 Status: cancelled
Lot 7 Has Options: No
Lot 7 Award Criterion (quality): API Sources
Contract Title: Etanercept
Contract Title: Infliximab IV
Contract Title: Methotrexate pens (25mg/1ml concentration)
Contract Title: Infliximab SC
Contract Title: Methotrexate syringes (25mg/1 ml concentration)
Contract Title: Methotrexate pens (50mg/1 ml concentration)
Contract Title: Methotrexate syringes (50mg/1ml concentration)
Award Title: Etanercept
Award Title: Infliximab IV
Award Title: Methotrexate pens (25mg/1ml concentration)
Award Title: Infliximab SC
Award Title: Methotrexate syringes (25mg/1 ml concentration)
Award Title: Methotrexate pens (50mg/1 ml concentration)
Award Title: Methotrexate syringes (50mg/1ml concentration)
{
"awards": [
{
"id": "010054-2025-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-141106",
"name": "Biogen Idec Ltd"
},
{
"id": "GB-FTS-95765",
"name": "Sandoz"
},
{
"id": "GB-FTS-57454",
"name": "Pfizer Ltd"
}
],
"title": "Etanercept"
},
{
"id": "010054-2025-2",
"relatedLots": [
"2"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-5312",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-FTS-107241",
"name": "Janssen Cilag Limited"
},
{
"id": "GB-FTS-141106",
"name": "Biogen Idec Ltd"
},
{
"id": "GB-FTS-4558",
"name": "Sandoz Ltd"
}
],
"title": "Infliximab IV"
},
{
"id": "010054-2025-3",
"relatedLots": [
"5"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4550",
"name": "Accord Healthcare Ltd"
},
{
"id": "GB-FTS-4551",
"name": "medac Pharma LLP"
}
],
"title": "Methotrexate pens (25mg/1ml concentration)"
},
{
"id": "010054-2025-4",
"relatedLots": [
"3"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-5312",
"name": "Celltrion Healthcare United Kingdom Limited"
}
],
"title": "Infliximab SC"
},
{
"id": "010054-2025-5",
"relatedLots": [
"4"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4550",
"name": "Accord Healthcare Ltd"
}
],
"title": "Methotrexate syringes (25mg/1 ml concentration)"
},
{
"id": "010054-2025-6",
"relatedLots": [
"6"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-141107",
"name": "Nordic Pharma Ltd"
}
],
"title": "Methotrexate pens (50mg/1 ml concentration)"
},
{
"id": "010054-2025-7",
"relatedLots": [
"7"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-141107",
"name": "Nordic Pharma Ltd"
}
],
"title": "Methotrexate syringes (50mg/1ml concentration)"
}
],
"bids": {
"statistics": [
{
"id": "36",
"measure": "bids",
"relatedLot": "1",
"value": 3
},
{
"id": "41",
"measure": "bids",
"relatedLot": "2",
"value": 4
},
{
"id": "46",
"measure": "bids",
"relatedLot": "5",
"value": 1
},
{
"id": "51",
"measure": "bids",
"relatedLot": "3",
"value": 1
},
{
"id": "56",
"measure": "bids",
"relatedLot": "4",
"value": 1
},
{
"id": "61",
"measure": "bids",
"relatedLot": "6",
"value": 1
},
{
"id": "66",
"measure": "bids",
"relatedLot": "7",
"value": 1
},
{
"id": "37",
"measure": "smeBids",
"relatedLot": "1",
"value": 0
},
{
"id": "42",
"measure": "smeBids",
"relatedLot": "2",
"value": 0
},
{
"id": "47",
"measure": "smeBids",
"relatedLot": "5",
"value": 0
},
{
"id": "52",
"measure": "smeBids",
"relatedLot": "3",
"value": 0
},
{
"id": "57",
"measure": "smeBids",
"relatedLot": "4",
"value": 0
},
{
"id": "62",
"measure": "smeBids",
"relatedLot": "6",
"value": 0
},
{
"id": "67",
"measure": "smeBids",
"relatedLot": "7",
"value": 0
},
{
"id": "38",
"measure": "foreignBidsFromEU",
"relatedLot": "1",
"value": 0
},
{
"id": "43",
"measure": "foreignBidsFromEU",
"relatedLot": "2",
"value": 0
},
{
"id": "48",
"measure": "foreignBidsFromEU",
"relatedLot": "5",
"value": 0
},
{
"id": "53",
"measure": "foreignBidsFromEU",
"relatedLot": "3",
"value": 0
},
{
"id": "58",
"measure": "foreignBidsFromEU",
"relatedLot": "4",
"value": 0
},
{
"id": "63",
"measure": "foreignBidsFromEU",
"relatedLot": "6",
"value": 0
},
{
"id": "68",
"measure": "foreignBidsFromEU",
"relatedLot": "7",
"value": 0
},
{
"id": "39",
"measure": "foreignBidsFromNonEU",
"relatedLot": "1",
"value": 0
},
{
"id": "44",
"measure": "foreignBidsFromNonEU",
"relatedLot": "2",
"value": 0
},
{
"id": "49",
"measure": "foreignBidsFromNonEU",
"relatedLot": "5",
"value": 0
},
{
"id": "54",
"measure": "foreignBidsFromNonEU",
"relatedLot": "3",
"value": 0
},
{
"id": "59",
"measure": "foreignBidsFromNonEU",
"relatedLot": "4",
"value": 0
},
{
"id": "64",
"measure": "foreignBidsFromNonEU",
"relatedLot": "6",
"value": 0
},
{
"id": "69",
"measure": "foreignBidsFromNonEU",
"relatedLot": "7",
"value": 0
},
{
"id": "40",
"measure": "electronicBids",
"relatedLot": "1",
"value": 3
},
{
"id": "45",
"measure": "electronicBids",
"relatedLot": "2",
"value": 4
},
{
"id": "50",
"measure": "electronicBids",
"relatedLot": "5",
"value": 1
},
{
"id": "55",
"measure": "electronicBids",
"relatedLot": "3",
"value": 1
},
{
"id": "60",
"measure": "electronicBids",
"relatedLot": "4",
"value": 1
},
{
"id": "65",
"measure": "electronicBids",
"relatedLot": "6",
"value": 1
},
{
"id": "70",
"measure": "electronicBids",
"relatedLot": "7",
"value": 1
}
]
},
"buyer": {
"id": "GB-FTS-115937",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"contracts": [
{
"awardID": "010054-2025-1",
"dateSigned": "2025-01-29T00:00:00Z",
"id": "010054-2025-1",
"status": "active",
"title": "Etanercept",
"value": {
"amount": 1700000,
"currency": "GBP"
}
},
{
"awardID": "010054-2025-2",
"dateSigned": "2025-01-29T00:00:00Z",
"id": "010054-2025-2",
"status": "active",
"title": "Infliximab IV",
"value": {
"amount": 44300000,
"currency": "GBP"
}
},
{
"awardID": "010054-2025-3",
"dateSigned": "2025-01-29T00:00:00Z",
"id": "010054-2025-3",
"status": "active",
"title": "Methotrexate pens (25mg/1ml concentration)",
"value": {
"amount": 5150000,
"currency": "GBP"
}
},
{
"awardID": "010054-2025-4",
"dateSigned": "2025-01-29T00:00:00Z",
"id": "010054-2025-4",
"status": "active",
"title": "Infliximab SC",
"value": {
"amount": 4200000,
"currency": "GBP"
}
},
{
"awardID": "010054-2025-5",
"dateSigned": "2025-01-29T00:00:00Z",
"id": "010054-2025-5",
"status": "active",
"title": "Methotrexate syringes (25mg/1 ml concentration)",
"value": {
"amount": 577000,
"currency": "GBP"
}
},
{
"awardID": "010054-2025-6",
"dateSigned": "2025-01-29T00:00:00Z",
"id": "010054-2025-6",
"status": "active",
"title": "Methotrexate pens (50mg/1 ml concentration)",
"value": {
"amount": 1000,
"currency": "GBP"
}
},
{
"awardID": "010054-2025-7",
"dateSigned": "2025-01-29T00:00:00Z",
"id": "010054-2025-7",
"status": "active",
"title": "Methotrexate syringes (50mg/1ml concentration)",
"value": {
"amount": 15000,
"currency": "GBP"
}
}
],
"date": "2025-03-19T09:15:55Z",
"description": "The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the twenty four (24) month contract duration and the twenty four (24) month extension period of the framework agreement.\n(SC Ref:793130)",
"id": "010054-2025",
"initiationType": "tender",
"language": "en",
"links": [
{
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000781799",
"rel": "canonical"
}
],
"ocid": "ocds-h6vhtk-04b34f",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"region": "UKM",
"streetAddress": "1 South Gyle Crescent"
},
"contactPoint": {
"email": "stephanie.mcniven2@nhs.scot",
"name": "Stephanie McNiven",
"telephone": "+44 1312756000"
},
"details": {
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"description": "Body governed by public law",
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics"
},
"id": "GB-FTS-115937",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
"roles": [
"buyer",
"centralPurchasingBody"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Maidenhead",
"postalCode": "SL6 3UD",
"region": "UK",
"streetAddress": "Biogen Building 5 Foundation Park, , Roxborough Way, Maidenhead, Berkshire, England,"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-141106",
"identifier": {
"legalName": "Biogen Idec Ltd"
},
"name": "Biogen Idec Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Slough",
"postalCode": "SL1 1QP",
"region": "UK",
"streetAddress": "1-7 The Switch"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-5312",
"identifier": {
"legalName": "Celltrion Healthcare United Kingdom Limited"
},
"name": "Celltrion Healthcare United Kingdom Limited",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "North Harrow",
"postalCode": "HA1 4HF",
"region": "UK",
"streetAddress": "Sage House, 319 Piner Road"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-4550",
"identifier": {
"legalName": "Accord Healthcare Ltd"
},
"name": "Accord Healthcare Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Reading",
"postalCode": "RG7 4SA",
"region": "UK",
"streetAddress": "Abbey House, 1650 Arlington Business Park, Theale"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-141107",
"identifier": {
"legalName": "Nordic Pharma Ltd"
},
"name": "Nordic Pharma Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Camberley, Surrey",
"postalCode": "GU15 3YL",
"region": "UK",
"streetAddress": "Park View, Riverside Way, Watchmoor Park"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-95765",
"identifier": {
"legalName": "Sandoz"
},
"name": "Sandoz",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Tadworth",
"postalCode": "KT20 7NS",
"region": "UK",
"streetAddress": "Walton Oaks, Dorking Road"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-57454",
"identifier": {
"legalName": "Pfizer Ltd"
},
"name": "Pfizer Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "High Wycombe",
"postalCode": "HP12 4EG",
"region": "UK",
"streetAddress": "50-100, Holmers Farm Way"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-107241",
"identifier": {
"legalName": "Janssen Cilag Limited"
},
"name": "Janssen Cilag Limited",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Camberley",
"postalCode": "GU16 7SR",
"region": "UK",
"streetAddress": "Frimley Business Park, Frimley"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-4558",
"identifier": {
"legalName": "Sandoz Ltd"
},
"name": "Sandoz Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Stirling",
"postalCode": "FK9 4NF",
"region": "UK",
"streetAddress": "Scion House, Innovation Park"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-4551",
"identifier": {
"legalName": "medac Pharma LLP"
},
"name": "medac Pharma LLP",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"streetAddress": "27 Chambers Street"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525"
},
"details": {
"url": "https://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts"
},
"id": "GB-FTS-324",
"identifier": {
"legalName": "Sheriff Court House"
},
"name": "Sheriff Court House",
"roles": [
"reviewBody"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"classification": {
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
},
"coveredBy": [
"GPA"
],
"description": "Supply of Cytokine Modulators to NHS Scotland.",
"id": "ocds-h6vhtk-04b34f",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"id": "1",
"relatedLot": "1"
},
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"id": "2",
"relatedLot": "2"
},
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"id": "3",
"relatedLot": "3"
},
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"id": "4",
"relatedLot": "4"
},
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"id": "5",
"relatedLot": "5"
},
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"id": "6",
"relatedLot": "6"
},
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"id": "7",
"relatedLot": "7"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"description": "5",
"name": "API Sources",
"type": "quality"
},
{
"description": "95",
"type": "price"
}
]
},
"description": "Supply of Etanercept to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
"hasOptions": false,
"id": "1",
"status": "cancelled",
"title": "Etanercept"
},
{
"awardCriteria": {
"criteria": [
{
"description": "5",
"name": "API Sources",
"type": "quality"
},
{
"description": "95",
"type": "price"
}
]
},
"description": "Supply of Infliximab IV to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.",
"hasOptions": false,
"id": "2",
"status": "cancelled",
"title": "Infliximab IV"
},
{
"awardCriteria": {
"criteria": [
{
"description": "5",
"name": "API Sources",
"type": "quality"
},
{
"description": "95",
"type": "price"
}
]
},
"description": "Supply of Infliximab SC to NHS Scotland.\nThe Authority intends to award this Lot as a single supplier framework per product line.",
"hasOptions": false,
"id": "3",
"status": "cancelled",
"title": "Infliximab SC"
},
{
"awardCriteria": {
"criteria": [
{
"description": "5",
"name": "API Sources",
"type": "quality"
},
{
"description": "95",
"type": "price"
}
]
},
"description": "Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
"hasOptions": false,
"id": "4",
"status": "cancelled",
"title": "Methotrexate syringes (25mg/1 ml concentration)"
},
{
"awardCriteria": {
"criteria": [
{
"description": "5",
"name": "API Sources",
"type": "quality"
},
{
"description": "95",
"type": "price"
}
]
},
"description": "Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
"hasOptions": false,
"id": "5",
"status": "cancelled",
"title": "Methotrexate pens (25mg/1ml concentration)"
},
{
"awardCriteria": {
"criteria": [
{
"description": "5",
"name": "API Sources",
"type": "quality"
},
{
"description": "95",
"type": "price"
}
]
},
"description": "Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
"hasOptions": false,
"id": "6",
"status": "cancelled",
"title": "Methotrexate pens (50mg/1 ml concentration)"
},
{
"awardCriteria": {
"criteria": [
{
"description": "5",
"name": "API Sources",
"type": "quality"
},
{
"description": "95",
"type": "price"
}
]
},
"description": "Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
"hasOptions": false,
"id": "7",
"status": "cancelled",
"title": "Methotrexate syringes (50mg/1ml concentration)"
}
],
"mainProcurementCategory": "goods",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a \u2018standstill period\u2019 of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"status": "complete",
"techniques": {
"hasFrameworkAgreement": true
},
"title": "NP47924 Cytokine Modulators"
}
}